Fusing graph transformer with multi-aggregate GCN for enhanced drug–disease associations prediction

Shihui He,Lijun Yun,Haicheng Yi
DOI: https://doi.org/10.1186/s12859-024-05705-w
IF: 3.307
2024-02-22
BMC Bioinformatics
Abstract:Identification of potential drug–disease associations is important for both the discovery of new indications for drugs and for the reduction of unknown adverse drug reactions. Exploring the potential links between drugs and diseases is crucial for advancing biomedical research and improving healthcare. While advanced computational techniques play a vital role in revealing the connections between drugs and diseases, current research still faces challenges in the process of mining potential relationships between drugs and diseases using heterogeneous network data.
biochemical research methods,biotechnology & applied microbiology,mathematical & computational biology
What problem does this paper attempt to address?
The paper aims to address the problem of identifying and characterizing potential associations between drugs and diseases, which is a critical challenge in drug discovery and disease treatment. Specifically, the goals of the paper include: 1. **Predicting Drug-Disease Associations**: Developing a new computational framework to predict potential associations between drugs and diseases, thereby accelerating the process of drug repositioning and reducing unknown adverse drug reactions. 2. **Utilizing Graph Neural Network Technology**: Proposing a method that combines Graph Transformer and Multi-aggregate Graph Convolutional Network, called WMAGT, for efficiently learning heterogeneous information graph representations. 3. **Improving Prediction Accuracy**: Experimentally validating that WMAGT outperforms other existing methods on 3 benchmark datasets, demonstrating significant improvements in understanding complex biological networks. In summary, this research aims to improve the accuracy of drug-disease association predictions through advanced computational methods, thereby promoting the development of drug repositioning and drug safety research.